CB-5339 NEW
Price | $50 | $75 | $128 |
Package | 5mg | 10mg | 25mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-16 |
Product Details
Product Name: CB-5339 | CAS No.: 1863952-15-1 |
Purity: 98.5% | Supply Ability: 10g |
Release date: 2024/11/16 |
Product Introduction
Bioactivity
名稱 | CB-5339 |
描述 | p97-IN-1 is a potent inhibitor of p97 with an IC 50 <30 nM [1]. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 50 mg/mL (121.22 mM), Sonication is recommended. |
關鍵字 | CB5339 | CB 5339 | 1HIndole4carboxamide,2methyl1[5,6,7,8tetrahydro4[(phenylmethyl)amino]pyrido[2,3d]pyrimidin2yl] | CB-5339 |
相關產(chǎn)品 | DBEQ | UPCDC30766 | MSC1094308 | ML241 hydrochloride | NMS-873 | MNS | ML240 | CB-5083 | ML241 |
相關庫 | 經(jīng)典已知活性庫 | 泛素化化合物庫 | 抗癌臨床化合物庫 | 藥物功能重定位化合物庫 | 抑制劑庫 | 臨床期小分子藥物庫 | 已知活性化合物庫 | 抗癌化合物庫 | 抗癌藥物庫 | 抗癌活性化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$39.00/2mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-11 | |
$1520.00/25mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-28 | |
$250.00/10gram |
VIP3Y
|
Wuhan Senwayer Century Chemical Co.,Ltd
|
2022-10-31 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY